<DOC>
	<DOC>NCT01558336</DOC>
	<brief_summary>The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.</brief_summary>
	<brief_title>Schistosoma Haematobium Infections and Praziquantel</brief_title>
	<detailed_description>A longitudinal study will be conducted to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1 year after treatment with a single dose of praziquantel 40mg/kg.</detailed_description>
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Schistosomiasis haematobia</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>School children Taking praziquantel</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Schistosoma haematobium</keyword>
	<keyword>schoolchildren</keyword>
	<keyword>Central Sudan</keyword>
	<keyword>Praziquantel</keyword>
</DOC>